ImmunityBio, Inc. is a clinical-stage biotech company developing next-generation therapies and vaccines that complement and amplify the immune system to defeat cancers and infectious diseases. Our broad immunotherapy and cell therapy platforms are designed to attack cancer and infectious pathogens by activating both the innate and adaptive immune system in an orchestrated manner. Our ultimate goal is to employ this approach to establish an “immunological memory” that confers long-term benefit for the patient.
Additional Info
Will your company display a new product or promote a new indication/enhanced feature(s) for an existing product in your booth?
Yes